share_log

CORRESP: CORRESP

SEC announcement ·  Apr 13 01:23
Summary by Futu AI
Apollomics Inc., a biopharmaceutical company, has responded to a comment from the SEC regarding its operations in China. The SEC's Division of Corporation Finance had requested clarification on the extent of Apollomics' operations in China, citing the need for specific disclosures about the risks associated with China-based companies. In a letter dated April 12, 2024, Apollomics clarified that it does not conduct the majority of its operations in China, stating that it is a Cayman Islands holding company with its business headquarters and management team based in California, USA. The company conducts most of its research and development efforts outside of China, with less than 20% of these activities taking place in Hong Kong and mainland China through its subsidiaries. Apollomics also highlighted that the majority of its cash and expenditures are held and incurred outside of China. This response follows the SEC's guidance on China-specific disclosures and addresses issues previously raised in a December 2021 letter.
Apollomics Inc., a biopharmaceutical company, has responded to a comment from the SEC regarding its operations in China. The SEC's Division of Corporation Finance had requested clarification on the extent of Apollomics' operations in China, citing the need for specific disclosures about the risks associated with China-based companies. In a letter dated April 12, 2024, Apollomics clarified that it does not conduct the majority of its operations in China, stating that it is a Cayman Islands holding company with its business headquarters and management team based in California, USA. The company conducts most of its research and development efforts outside of China, with less than 20% of these activities taking place in Hong Kong and mainland China through its subsidiaries. Apollomics also highlighted that the majority of its cash and expenditures are held and incurred outside of China. This response follows the SEC's guidance on China-specific disclosures and addresses issues previously raised in a December 2021 letter.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.